A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Tolvaptan (Primary)
- Indications Hyponatraemia
- Focus Therapeutic Use
- Acronyms INSIGHT
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 14 Jun 2017 New trial record